The clinical relevance of CD49b was assessed utilizing a patient cohort that included 57 osteosarcoma samples and demonstrated that elevated expression is significantly associated with metastasis and poorer 5 year overall survival. The gene discussed is ITGA2; the disease is osteosarcoma.